Literature DB >> 2646218

Modulation of phospholipase A2 lytic activity by actin and myosin.

D A Dubose1, D Shepro, H B Hechtman.   

Abstract

Prostacyclin (PGI2) production is closely coupled with endothelial cell shape and F-actin distribution in vitro. These findings may implicate cytoskeletal constituents in a mechanism regulating eicosanoid metabolism. To determine the potential for such a regulatory mechanism, cytoskeletal protein effects on the rate-limiting eicosanoid cascade enzyme (phospholipase A2; PLA2) were studied. Membrane phospholipid degradation was indirectly determined by spectrophotometric measurement of PLA2-induced rat red blood cell ghost (RBC-G) hemolysis. PLA2 was incubated with actin (skeletal, smooth, or nonmuscle cell) at a nonmuscle cell concentration (100 microM) and then exposed to the RBC-G. Comparisons in the presence or absence of actin revealed that F-actin stimulated whereas G-actin suppressed PLA2 lytic behavior significantly (P less than 0.05). When a 10: or 100:1 F-actin to myosin ratio was used, the F-actin stimulatory effect was significantly (P less than 0.05) reduced. These findings suggest that the in vitro correlation between PGI2 production and endothelial cell shape may be the result of PLA2 regulation by cytoskeletal elements that impart cellular form.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646218     DOI: 10.1007/bf00918960

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  Organization of phospholipids in human red cell membranes as detected by the action of various purified phospholipases.

Authors:  R F Zwaal; B Roelofsen; P Comfurius; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1975-09-16

2.  Microfilament bundles and cell shape are related to adhesiveness to substratum and are dissociable from growth control in cultured fibroblasts.

Authors:  M C Willingham; K M Yamada; S S Yamada; J Pouysségur; I Pastan
Journal:  Cell       Date:  1977-03       Impact factor: 41.582

Review 3.  Inhibition of phospholipase.

Authors:  G J Blackwell; R J Flower
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

4.  Binding of aldolase to actin-containing filaments. Evidence of interaction with the regulatory proteins of skeletal muscle.

Authors:  T P Walsh; D J Winzor; F M Clarke; C J Masters; D J Morton
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

5.  Action of pure phospholipase A 2 and phospholipase C on human erythrocytes and ghosts.

Authors:  B Roelofsen; R F Zwaal; P Comfurius; C B Woodward; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1971-09-14

6.  Eicosanoid modulation of stress fibers in cultured bovine aortic endothelial cells.

Authors:  S L Welles; D Shepro; H B Hechtman
Journal:  Inflammation       Date:  1985-12       Impact factor: 4.092

7.  Endothelial serotonin uptake and mediation of prostanoid secretion and stress fiber formation.

Authors:  D Shepro; H B Hechtman
Journal:  Fed Proc       Date:  1985-07

8.  Correlation among endothelial cell shape, F-actin arrangement, and prostacyclin synthesis.

Authors:  D A Dubose; D Shepro; H B Hechtman
Journal:  Life Sci       Date:  1987-02-02       Impact factor: 5.037

9.  The lipid requirement of the (Ca2+ + Mg2+)-ATPase in the human erythrocyte membrane, as studied by various highly purified phospholipases.

Authors:  B Roelofsen; H J Schatzmann
Journal:  Biochim Biophys Acta       Date:  1977-01-04

10.  Interactions between glycolytic enzymes and components of the cytomatrix.

Authors:  C Masters
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more
  1 in total

1.  Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein.

Authors:  Brawnie Petrov; Ayat Aldoori; Cindy James; Kefeng Yang; Guillermo Perez Algorta; Aejin Lee; Liwen Zhang; Tao Lin; Reem Al Awadhi; Jonathan R Parquette; Arpad Samogyi; L Eugene Arnold; Mary A Fristad; Barbara Gracious; Ouliana Ziouzenkova
Journal:  Transl Psychiatry       Date:  2018-03-13       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.